1. |
Shishodia S, Aggarwal BB. Nuclear factor-kappa B activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer [J]. Cancer Treat Res, 2004; 119∶139.
|
2. |
Shukla S, MacLennan GT, Fu P, et al. Nuclear factor-kappa B/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression [J]. Neoplasia, 2004; 6(4)∶390.
|
3. |
Andela VB, Schwarz EM, Puzas JE, et al. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappa B [J]. Cancer Res, 2000; 60(23)∶6557.
|
4. |
Jiang Y, Cui L, Yie TA, et al. Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by I kappa B beta [J]. Oncogene, 2001; 20(18)∶2254.
|
5. |
Hah N, Lee ST. An absolute role of the PKC-dependent NF-kappa B activation for induction of MMP-9 in hepatocellular carcinoma cells [J]. Biochem Biophys Res Commun, 2003; 305(2)∶428.
|
6. |
Ortega N, Jonca F, Vincent S, et al. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype [J]. Am J Pathol, 1997; 151(5)∶1215.
|
7. |
Li Z, Ren Y, Wu QC, et al. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines [J]. Chin Med J (Engl), 2004; 117(1)∶107.
|
8. |
張克君, 高焱明, 楊堂斗, 等. 核因子-κB p65、IκB-α在肝炎相關性肝細胞癌中的表達及臨床意義 [J]. 實用腫瘤雜志, 2004; 19(3)∶216.
|
9. |
張克君, 高焱明. 核因子-κB p65在肝炎相關性肝細胞癌中的表達及意義 [J]. 中國癌癥雜志, 2005; 15(1)∶12.
|